{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:40:09Z","timestamp":1793900409040,"version":"4.8.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>About 20% of gastric cancer patients have peritoneal metastases diagnosed preoperatively or intraoperatively, and the median survival time of advanced patients with peritoneal metastases is only 3\u20136\u00a0months, with a 5-year survival rate of less than 2%. Some guidelines indicate that hyperthermic intraperitoneal chemotherapy (HIPEC) can be used in gastric cancer with limited peritoneal metastasis, which can effectively prolong survival and improve the quality of survival. However, HIPEC is controversial in preventing peritoneal metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis study is reported according to the PRISMA 2020 and AMSTAR guidelines. The authors searched randomized controlled trials (RCTs) in PubMed, Cochrane Library, Web Of Science, and Embase until 1 April 2025 and applied methods used for high-quality systematic reviews. Clinical data including overall survival, disease-free survival, peritoneal recurrence rate, incidence of adverse reactions, and complications were analyzed using RevMan 5.4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Nine RCTs met the inclusion criteria (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =\u00a01021 patients). Meta-analysis showed that the rate of peritoneal metastasis was significantly lower in the HIPEC group than in the control group (OR: 0.24; 95% CI: 0.16\u20130.35), the rate of distant metastasis was significantly lower in the HIPEC group (OR: 0.45, 95% CI: 0.28\u20130.71), the 3-year survival rate was prolonged in the HIPEC group compared with the control group (OR: 1.48; 95% CI: 1.01\u20132.17), the 3-year disease-free survival rate was significantly higher in the HIPEC group (OR: 1.92; 95% CI: 1.23\u20133.00), and HIPEC was not associated with an increased number of complications and adverse events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>HIPEC has a favorable effect on prolonging survival and reducing peritoneal metastasis and distant metastasis in patients with advanced gastric cancer, and does not significantly increase adverse reactions and complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003901","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:07:00Z","timestamp":1771870020000},"page":"5101-5110","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["The survival and peritoneal metastasis of hyperthermic intraperitoneal chemotherapy in advanced gastric cancer: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1097","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8406-8043","authenticated-orcid":false,"given":"Jinmeng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of General Surgery, North China University of Science and Techology Affiliated Kailuan General Hospital, Tangshan, China"},{"name":"North China University of Science and Techology, Tangshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilong","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of General Surgery, North China University of Science and Techology Affiliated Kailuan General Hospital, Tangshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of General Surgery, North China University of Science and Techology Affiliated Kailuan General Hospital, Tangshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QingSong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, North China University of Science and Techology Affiliated Kailuan General Hospital, Tangshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, North China University of Science and Techology Affiliated Kailuan General Hospital, Tangshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, North China University of Science and Techology Affiliated Kailuan General Hospital, Tangshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"R1-20260512","doi-asserted-by":"crossref","first-page":"635\u201348","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"R2-20260512","first-page":"229\u201363","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca A Cancer J Clinicians"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"839\u201345","DOI":"10.1007\/s12029-021-00652-8","article-title":"The barriers and facilitators of gastric cancer screening: a systematic review","volume":"52","author":"Hatamian","year":"2021","journal-title":"J Gastrointestinal Cancer"},{"key":"R4-20260512","first-page":"26\u201338","article-title":"Epidemiology of gastric cancer: global trends, risk factors and prevention","volume":"14","author":"Rawla","year":"2019","journal-title":"Gastroenterol Rev\/Prz Gastroenterol"},{"key":"R5-20260512","doi-asserted-by":"crossref","first-page":"584\u201390","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chinese Med J"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"445\u201348","DOI":"10.1016\/j.amjsurg.2022.01.024","article-title":"Patterns of gastric cancer metastasis in the United States","volume":"224","author":"Sirody","year":"2022","journal-title":"Am J Surg"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"11\u201322","DOI":"10.1007\/s10120-019-00978-0","article-title":"Peritoneal metastasis in gastric cancer: results from the German database","volume":"23","author":"Rau","year":"2020","journal-title":"Gastric Cancer"},{"key":"R8-20260512","first-page":"283\u201398","article-title":"Looking up: recent advances in understanding and treating peritoneal carcinomatosis","volume":"65","author":"Lambert","year":"2015","journal-title":"Ca A Cancer J Clinicians"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000658-198807000-00005","article-title":"Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding","volume":"208","author":"Fujimoto","year":"1988","journal-title":"Ann Surg"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"437\u201344","DOI":"10.1016\/S0039-6060(96)80145-0","article-title":"Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination","volume":"119","author":"Yonemura","year":"1996","journal-title":"Surgery"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"1\u20134","DOI":"10.1016\/j.ejca.2017.03.030","article-title":"The 30-year experience\u2014A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer","volume":"79","author":"Desiderio","year":"2017","journal-title":"Eur J Cancer"},{"key":"R12-20260512","first-page":"688\u201391","article-title":"Hyperthermic intraperitoneal chemotherapy","volume":"39","author":"Aljundi","year":"2024","journal-title":"J PeriAnesthesia Nurs"},{"key":"R13-20260512","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Meth"},{"key":"R15-20260512","first-page":"100082","article-title":"Transparency in the reporting of artificial intelligence\u2013the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R16-20260512","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12885-021-07925-2","article-title":"Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery","volume":"21","author":"Fan","year":"2021","journal-title":"BMC Cancer"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"239\u201345","DOI":"10.1080\/02656736.2022.2028018","article-title":"A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer","volume":"39","author":"Liu","year":"2022","journal-title":"Int J Hyperthermia"},{"key":"R18-20260512","doi-asserted-by":"crossref","first-page":"529\u201334","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<529::AID-CNCR3>3.0.CO;2-9","article-title":"Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma","volume":"85","author":"Fujimoto","year":"1999","journal-title":"Cancer: Interdiscip Int J Am Cancer Soc"},{"key":"R19-20260512","doi-asserted-by":"crossref","first-page":"2405\u201311","DOI":"10.1016\/j.ejso.2019.07.030","article-title":"Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients","volume":"45","author":"Reutovich","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"11491\u201398","DOI":"10.1007\/s00432-023-05019-z","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study","volume":"149","author":"Yu","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4251\/wjgo.v12.i7.782","article-title":"Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer","volume":"12","author":"Xie","year":"2020","journal-title":"World J Gastrointestinal Oncol"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"1083\u201388","DOI":"10.3892\/etm.2014.1599","article-title":"Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer","volume":"7","author":"Cui","year":"2014","journal-title":"Exp Ther Med"},{"key":"R23-20260512","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1186\/s12885-019-6125-z","article-title":"Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study","volume":"19","author":"Beeharry","year":"2019","journal-title":"BMC Cancer"},{"key":"R24-20260512","first-page":"140\u201345","article-title":"Efficacy of adjuvant intravenous chemotherapy combined with intraperitoneal hyperthermic chemotherapy in treatment of gastric cancer after radical gastrectomy","volume":"34","author":"Gong","year":"2019","journal-title":"J Pract Oncol"},{"key":"R25-20260512","first-page":"6991\u201398","article-title":"Mechanisms of peritoneal dissemination in gastric cancer","volume":"14","author":"Sun","year":"2017","journal-title":"Oncol Lett"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"358\u201363","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer: Interdiscip Int J Am Cancer Soc"},{"key":"R27-20260512","first-page":"387\u201399","article-title":"The surgical treatment of cancer of the stomach","volume":"65","author":"Yamada","year":"1980","journal-title":"Int Surg"},{"key":"R28-20260512","doi-asserted-by":"crossref","first-page":"116\u201323","DOI":"10.1002\/ags3.12060","article-title":"Treatment of patients with peritoneal metastases from gastric cancer","volume":"2","author":"Kitayama","year":"2018","journal-title":"Ann Gastroenterol Surg"},{"key":"R29-20260512","first-page":"240\u201348","article-title":"Exploring the efficacy of hyperthermic intraperitoneal perfusion chemotherapy in gastric cancer: meta-analysis based on randomized controlled trials","volume":"32","author":"Chen","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"R30-20260512","doi-asserted-by":"crossref","first-page":"2435\u201350","DOI":"10.1097\/JS9.0000000000000457","article-title":"Effect of hyperthermic intraperitoneal chemotherapy on survival and recurrence rates in advanced gastric cancer: a systematic review and meta-analysis","volume":"109","author":"Patel","year":"2023","journal-title":"Int J Surg"},{"key":"R31-20260512","doi-asserted-by":"crossref","first-page":"5926\u201336","DOI":"10.1177\/0300060519882545","article-title":"Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of the randomized controlled trials","volume":"47","author":"Liu","year":"2019","journal-title":"J Int Med Res"},{"key":"R32-20260512","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/1471-2407-12-526","article-title":"Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials","volume":"12","author":"Sun","year":"2012","journal-title":"BMC Cancer"},{"key":"R33-20260512","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/jcm8101685","article-title":"Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer\u2014a systematic review","volume":"8","author":"Brenkman","year":"2019","journal-title":"J Clin Med"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:25:40Z","timestamp":1778581540000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003901","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"2025-05-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}